Article
MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
Oncogene - 22 May 2014
Sun T, Wang X, He H H, Sweeney C J, Liu S X, Brown M, Balk S, Lee G-Sm, Kantoff P W
Abstract excerpt
Hormone-sensitive prostate cancer typically progresses to castration resistant prostate cancer (CRPC) after the androgen deprivation therapy. We investigated the impact of microRNAs (miRs) in the transition of prostate cancer to CRPC. MiR-221/-222 was highly expressed in bone metastatic CRPC tumor specimens. We previously demonstrated that transient overexpression of miR-221/-222 in LNCaP promoted the development...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
